Clinical trial
Mitomycin and Mitoxantrone in Treating Patients With Acute Myelogenous Leukemia
NCT00003003 · Dartmouth-Hitchcock Medical Center, Other · Completed
Key facts
| NCT number | NCT00003003 |
|---|---|
| Title | Mitomycin and Mitoxantrone in Treating Patients With Acute Myelogenous Leukemia |
| Official title | A Pilot Clinical Trial of Mitomycin C Modulation of Multidrug Resistance Proteins and a Phase I Evaluation of Mitomycin C and Mitoxantrone in Patients With Acute Myelogenous Leukemia |
| Lead sponsor | Dartmouth-Hitchcock Medical Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Leukemia |
| Intervention type | Biological, Drug |
| Interventions | sargramostim, mitomycin C, mitoxantrone hydrochloride |
| Enrollment | 29 |
| Start date | Sep 1, 1996 |
| Primary completion | Aug 1, 2000 |
| Completion | Aug 1, 2000 |
| First posted | Aug 12, 2004 |
| Last update posted | Mar 19, 2018 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: